tiprankstipranks
Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ:BMRN
US Market
Want to see BMRN full AI Analyst Report?

BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?

2,444 Followers

BioMarin Pharmaceutical (BMRN) Ownership Overview

0.46%32.07%0.97%22.05%44.46%
0.97% Other Institutional Investors
22.05% ETFs
44.46% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 55.08% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 44.46% is owned by Public Companies and Individual Investors.
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 33.03% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 22.05% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 11, 2026
xxxxxxxxxxxxx
$176682
Mar 12, 2026
xxxxxxxxxxxxx
$996744
Feb 26, 2026
xxxxxxxxxxxxx
$381901
Feb 26, 2026
xxxxxxxxxxxxx
$1599103

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$822593766
Mar 31, 2024
xxxxxxxxxxxxx
$11688402
Mar 31, 2024
xxxxxxxxxxxxx
$398936730
Mar 31, 2024
xxxxxxxxxxxxx
$801819342

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
16,655,429Institution8.62%981,837,540
15,183,140Institution7.86%895,046,103
14,561,759Institution7.53%858,415,693
14,194,005Institution7.34%836,736,595
12,190,738Institution6.31%718,644,005
11,483,325Institution5.94%676,942,009
7,062,077Institution3.65%416,309,439
5,355,459Institution2.77%315,704,308
5,179,450Institution2.68%305,328,578
5,143,616Institution2.66%303,216,163

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
15,183,140Institution7.86%895,046,103
11,483,325Institution5.94%676,942,009
5,179,450Institution2.68%305,328,578
5,143,616Institution2.66%303,216,163
2,576,251Institution1.33%151,869,996
2,369,741Institution1.23%139,696,232
2,152,092Institution1.11%126,865,823
1,962,240Institution1.02%115,674,048
1,594,857Institution0.83%94,016,820
1,118,519Institution0.58%65,936,695

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,616,111Institution3.42%390,019,743
6,143,206Institution3.18%351,514,247
4,433,137Institution2.29%253,664,099
2,559,860Institution1.32%146,475,189
2,217,617Institution1.15%126,892,045
1,784,439Institution0.92%104,639,503
1,449,176Institution0.75%85,428,925
1,395,186Institution0.72%82,246,215
1,385,699Institution0.72%81,686,956
984,061Institution0.51%57,705,337

FAQ

Who Owns Biomarin Pharmaceutical Inc. (BMRN)?
According to the latest TipRanks data, approximately 0.97% of the company's stock is held by institutional investors, 0.46% is held by insiders, and 44.46% is held by retail investors.
    What percentage of Biomarin Pharmaceutical Inc. (BMRN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.97% of Biomarin Pharmaceutical Inc. (BMRN) stock is held by institutional investors.
      What percentage of Biomarin Pharmaceutical Inc. (BMRN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 44.46% of Biomarin Pharmaceutical Inc. (BMRN) stock is held by retail investors.
        Who owns the most shares of Biomarin Pharmaceutical Inc. (BMRN)?
        Vanguard owns the most shares of Biomarin Pharmaceutical Inc. (BMRN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.